One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation.
di Francesco
Fabrizio
F
Cautero
Nicola
N
Vincenzi
Paolo
P
Nicolini
Daniele
D
De Luca
Stefano
S
Vecchi
Andrea
A
Garelli
Paolo
P
Martorelli
Giacomo
G
Gentili
Marco
M
Risaliti
Andrea
A
Boemi
Massimo
M
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D016035:Pancreas Transplantation; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016559:Tacrolimus / Q000008:administration & dosage; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D000068338:Everolimus; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus